Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to 'Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype' [Journal of Thoracic Oncology Volume 21 Issue 4 (2026) 103529].

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Same author

Quantitative MRI-Based T Category in Pleural Mesothelioma: Analysis of a Large Real-World Cohort.

Academic radiology·2026

Same author

Candidate biomarkers to identify mesothelioma patients at risk of developing venous thromboembolism post-surgery.

Scientific reports·2026

Same author

Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025

Same author

Recurrence Patterns and Management after Pleurectomy Decortication for Pleural Mesothelioma.

Annals of surgery·2025

Same author

Characteristics of Long-term Survivors With Malignant Pleural Mesothelioma.

The Annals of thoracic surgery·2024

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Recent advances in mesothelioma staging.

William G Richards¹

¹Division of Thoracic Surgery, Harvard Medical School, Brigham and Women's Hospital, BWH Tissue and Blood Repository, Boston, Massachusetts 02115, USA. wrichards@partners.org

Seminars in Thoracic and Cardiovascular Surgery

|October 14, 2009

Summary

A standardized staging system for malignant pleural mesothelioma is needed for consistent clinical practice and research. Refining criteria with pathology data will improve patient stratification and treatment selection.

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Related Experiment Videos

Last Updated: Jun 19, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Area of Science:

Oncology
Pathology

Background:

Malignant pleural mesothelioma lacks a consensus staging system, hindering clinical practice and research.
Existing systems struggle with the cancer's unique biology and heterogeneous prognosis.

Observation:

Difficulty in conforming mesothelioma to current staging systems due to its unique biology.
Varied patient prognosis based on tumor histology impacts treatment and research.

Findings:

A consensus staging system is crucial for comparing outcomes across institutions and studies.
Data-driven refinement of staging criteria is necessary for accurate patient stratification.

Implications:

Improved patient stratification based on survival and tumor biology.
Enhanced selection of optimal treatments for individual mesothelioma cases.
Facilitation of more reliable multi-institutional and multi-study research outcomes.